Literature DB >> 26445827

Cartilage Tissue Engineering: What Have We Learned in Practice?

Pauline M Doran1.   

Abstract

Many technologies that underpin tissue engineering as a research field were developed with the aim of producing functional human cartilage in vitro. Much of our practical experience with three-dimensional cultures, tissue bioreactors, scaffold materials, stem cells, and differentiation protocols was gained using cartilage as a model system. Despite these advances, however, generation of engineered cartilage matrix with the composition, structure, and mechanical properties of mature articular cartilage has not yet been achieved. Currently, the major obstacles to synthesis of clinically useful cartilage constructs are our inability to control differentiation to the extent needed, and the failure of engineered and host tissues to integrate after construct implantation. The aim of this chapter is to distil from the large available body of literature the seminal approaches and experimental techniques developed for cartilage tissue engineering and to identify those specific areas requiring further research effort.

Entities:  

Keywords:  Bioreactor; Dedifferentiation; Hypertrophy; Scaffold; Stem cell; Three-dimensional culture; Tissue integration

Mesh:

Year:  2015        PMID: 26445827     DOI: 10.1007/978-1-4939-2938-2_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  Enzyme Pretreatment plus Locally Delivered HB-IGF-1 Stimulate Integrative Cartilage Repair In Vitro.

Authors:  Paul H Liebesny; Keri Mroszczyk; Hannah Zlotnick; Han-Hwa Hung; Eliot Frank; Bodo Kurz; Gustavo Zanotto; David Frisbie; Alan J Grodzinsky
Journal:  Tissue Eng Part A       Date:  2019-09-03       Impact factor: 3.845

2.  Effects of antigen removal on a porcine osteochondral xenograft for articular cartilage repair.

Authors:  Steve Elder; Hudson Chenault; Paul Gloth; Katie Webb; Ruth Recinos; Emily Wright; Dalton Moran; James Butler; Abdolsamad Borazjani; Avery Cooley
Journal:  J Biomed Mater Res A       Date:  2018-05-25       Impact factor: 4.396

3.  miR-134 inhibits chondrogenic differentiation of bone marrow mesenchymal stem cells by targetting SMAD6.

Authors:  Shaogang Xu; Xuejian Wu
Journal:  Biosci Rep       Date:  2019-01-30       Impact factor: 3.840

4.  Lipid phosphatase SHIP-1 regulates chondrocyte hypertrophy and skeletal development.

Authors:  Eui-Young So; Changqi Sun; Keith Q Wu; Adam Driesman; Susan Leggett; Mauricio Isaac; Travis Spangler; Patrycja M Dubielecka-Szczerba; Anthony M Reginato; Olin D Liang
Journal:  J Cell Physiol       Date:  2019-07-09       Impact factor: 6.384

5.  A systems biology approach to defining regulatory mechanisms for cartilage and tendon cell phenotypes.

Authors:  A J Mueller; S R Tew; O Vasieva; P D Clegg; E G Canty-Laird
Journal:  Sci Rep       Date:  2016-09-27       Impact factor: 4.379

Review 6.  Genetically modified mesenchymal stromal cells in cancer therapy.

Authors:  Elizabeth K Sage; Ricky M Thakrar; Sam M Janes
Journal:  Cytotherapy       Date:  2016-11       Impact factor: 5.414

7.  Hypertrophic differentiation of mesenchymal stem cells is suppressed by xanthotoxin via the p38‑MAPK/HDAC4 pathway.

Authors:  Zhen Cao; Yun Bai; Chuan Liu; Ce Dou; Jianmei Li; Junyu Xiang; Chunrong Zhao; Zhao Xie; Qiang Xiang; Shiwu Dong
Journal:  Mol Med Rep       Date:  2017-06-29       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.